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Patient and carer experiences of clinical 
uncertainty and deterioration, in the face 
of limited reversibility: A comparative 
observational study of the AMBER care 
bundle
Katherine Bristowe1, Irene Carey2, Adrian Hopper2, Susanna 
Shouls2, Wendy Prentice3, Ruth Caulkin2, Irene J Higginson1 and 
Jonathan Koffman1
Abstract
Background: Clinical uncertainty is emotionally challenging for patients and carers and creates additional pressures for those 
clinicians in acute hospitals. The AMBER care bundle was designed to improve care for patients identified as clinically unstable, 
deteriorating, with limited reversibility and at risk of dying in the next 1–2 months.
Aim: To examine the experience of care supported by the AMBER care bundle compared to standard care in the context of clinical 
uncertainty, deterioration and limited reversibility.
Design: A comparative observational mixed-methods study using semi-structured qualitative interviews and a followback survey.
Setting/participants: Three large London acute tertiary National Health Service hospitals. Nineteen interviews with 23 patients 
and carers (10 supported by AMBER care bundle and 9 standard care). Surveys completed by next of kin of 95 deceased patients 
(59 AMBER care bundle and 36 standard care).
Results: The AMBER care bundle was associated with increased frequency of discussions about prognosis between clinicians and 
patients (χ2 = 4.09, p = 0.04), higher awareness of their prognosis by patients (χ2 = 4.29, p = 0.04) and lower clarity in the information 
received about their condition (χ2 = 6.26, p = 0.04). Although the consistency and quality of communication were not different between 
the two groups, those supported by the AMBER care bundle described more unresolved concerns about caring for someone at home.
Conclusion: Awareness of prognosis appears to be higher among patients supported by the AMBER care bundle, but in this small 
study this was not translated into higher quality communication, and information was judged less easy to understand. Adequately 
powered comparative evaluation is urgently needed.
Keywords
Palliative care, terminal care, end-of-life care, communication, evaluation, satisfaction, hospital care, home care
1 King’s College London, Cicely Saunders Institute, Department of 
Palliative Care, Policy and Rehabilitation, London, UK
2 Guy’s and St Thomas’ NHS Foundation Trust, London, UK
3 King’s College Hospital NHS Foundation Trust, London, UK
578990 PMJ0010.1177/0269216315578990Palliative MedicineBristowe et al.
research-article2015
Original Article
Corresponding author:
Jonathan Koffman, King’s College London, Cicely Saunders Institute, 
Department of Palliative Care, Policy and Rehabilitation, Bessemer 
Road, London SE5 9PJ, UK.
Email: Jonathan.koffman@kcl.ac.uk
What is already known about the topic?
•• Clinical uncertainty towards the end of life is emotionally challenging for patients and carers and professionally challenging for 
clinicians.
•• Poor communication is a common problem in health care, especially in the more advanced stages of disease.
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What this paper adds?
•• The AMBER care bundle may improve awareness of prognosis and frequency of discussions between clinicians and patients and 
carers in the presence of clinical uncertainty. The AMBER care bundle did not appear to improve patient or family reported 
views of communication, and those who were cared for supported by AMBER had more concerns regarding home care.
Implications for practice, theory or policy
•• Poor communication in the acute hospital setting continues to be an issue. Robust evaluation of the AMBER care bundle is 
urgently needed.
Introduction
Clinical uncertainty towards the end of life is distressing for 
patients and families.1–3 However, sharing the clinical situa-
tion, including uncertainty, is central to establishing prefer-
ences and priorities, enabling collaborative decision making4 
and empowering patients and carers.5–7 While clinicians’ dis-
closure of clinical uncertainty with patients can be associated 
with increased satisfaction,8,9 without explanation it is asso-
ciated with poor satisfaction, mistrust and loss of confidence 
in the clinicians.10–13
Recent reports have highlighted failings in open and 
honest communication with patients and carers.14,15 Care 
in acute hospitals often focuses on immediate clinical 
problems with little recognition of transitions between 
clinical phases16 and inadequate communication with 
patients and families.17 Throughout their last year of life, 
people spend up to 1 month in hospital; currently, 53% of 
all deaths in England occur in hospital,18 despite most 
people expressing a preference to be cared for, and die, at 
home.19 This has led to calls for preferences and priorities 
to be discussed earlier in patients’ disease trajectories.20
The AMBER care bundle was developed to improve 
care for patients in the acute hospital setting who are dete-
riorating, clinically unstable, with limited reversibility and 
at risk of dying in the next 1–2 months.21 This intervention 
has an algorithmic approach and is intended to encourage 
the clinical team to develop and document a clear medical 
plan and consider anticipated outcomes and resuscita- 
tion and escalation status; this is revisited daily (see 
Supplementary Appendix 1). The bundle also aims to 
increase frequency of communication with patients and 
family regarding treatment plans, preferred place of care 
and other concerns. While it prompts advance care plan-
ning, the AMBER care bundle differs from advance care 
planning tools because it shapes current management as 
well as plans for future care. The AMBER care bundle has 
been identified as a key enabler in the transforming end- 
of-life care in acute hospital programme22 and is now being 
piloted or used across 38 hospitals in England. Moreover, it 
is also being piloted in nine hospitals in New South Wales, 
Australia. Importantly, it has not yet been evaluated in a 
comparative study.23 This study, therefore, aimed to exam-
ine the experience of care supported by the AMBER care 
bundle compared to standard care in the context of clinical 
uncertainty, deterioration and limited reversibility.
Methods
Design
In this mixed-methods24 observational study, we compared 
the experiences of care for people supported by the AMBER 
care bundle with those receiving standard care, using con-
temporary qualitative interviews with patients and carers 
and followback surveys of bereaved caregivers.
Setting
There were three large London acute tertiary National 
Health Service (NHS) hospitals: two where the AMBER 
care bundle was fully implemented (comparison wards 
not possible) and hospital 3 with implementation on five 
wards (permitting comparison). The AMBER care bun-
dle wards in hospital 3 were as follows: one respiratory, 
two endocrinology, one neurology and one health and 
ageing. The comparison (standard care) wards were as 
follows: two acute medical, two health and ageing and 
one stroke.
Contemporary interviews
Purposive sampling. We purposively sampled for heteroge-
neity across the two groups in order to understand how 
care was perceived and understood among different people 
with different characteristics. Potential patient participants 
under the care of a palliative care team were selected 
according to the following criteria:
•• AMBER care bundle status
• AMBER – supported by the AMBER care 
bundle (hospitals 1–3)
•  Comparison – would be appropriate for care 
supported by the AMBER care bundle if 
they were on an AMBER care bundle ward 
(hospital 3 only)
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•• Disease
• Cancer
• Non-cancer.
A family member was approached where the patient 
was too unwell to participate. Potential participants were 
not approached for the study if they lacked capacity to pro-
vide informed consent, were considered too distressed or 
were too unwell to participate.
Recruitment. Identification and first approach for the study 
was by the palliative care team (February–June 2013). Par-
ticipants provided informed consent before commencing 
the interview with the researcher (K.B.), a sociolinguist 
with extensive experience of interviewing in palliative care 
research.
Data collection. The topic guide, shaped by a literature 
review, explored participants’ experiences of care and 
involvement in treatment decisions while in hospital, 
including the following:
Illness history
•• Reason for admission and recent illness
•• Patient’s main problems, symptoms and concerns
•• Whether and how the health-care team have been 
able to help with these concerns
Information and communication
•• Clarity of information
•• Consistency of information
•• Opportunities to ask questions
•• How patient or carer concerns were managed
•• Whether they felt that their concerns were listened to
Involvement in decision making
•• Involvement in decision about the patient’s care
•• Opportunities to talk about the future and future 
care
•• Unresolved concerns
Experience of care provided
•• Confidence in the care and treatment provided
•• Experiences of how different care providers had 
worked together.
All interviews were audio-recorded and transcribed verba-
tim. Recruitment continued until data saturation was achieved, 
and no new themes were emerging from the interviews.
Analysis. All interviews were analysed by K.B. using 
thematic analysis in five stages: familiarisation, coding, 
theme development, defining themes and reporting.25  
To address issues of analytical rigour and trustworthiness, 
a subset of transcripts were double-coded by J.K. A 
re-iterant process of discussing areas of agreement and 
disagreement took place between K.B. and J.K. to achieve 
consensus. Alternative interpretations were incorporated 
in the analysis. The analysis was further tested during 
discussions with colleagues and meetings of the project 
advisory steering group. Attention was also paid to non-
confirmatory cases where emerging themes contradicted 
more common ideas.26 Comparison was made between the 
AMBER care bundle and comparison groups for each 
emergent theme. To preserve anonymity, participants were 
pseudo-anonymised. Analysis was managed using NVivo 
qualitative analysis software (Version 10).
Followback survey
Identification. Next of kin (NOK) were identified from 
electronic patient records (EPRs) for patients who had died 
within 100 days of discharge following an admission 
between December 2011 and December 2012. One group 
had received care supported by the AMBER care bundle; 
the other was a comparison group. Comparison patients 
were identified by a hospital consultant and clinical nurse 
specialist independently examining content of EPR data to 
identify patients who, all things being equal, would have 
been appropriate for care supported by the AMBER care 
bundle if they were on an AMBER care bundle ward. Cri-
teria for selection were deterioration, clinical instability, 
limited reversibility and being at risk of dying within 1–2 
months as available in clinical records.
Recruitment. All identified NOK were sent a letter from 
the palliative care team 4–10 months following bereave-
ment, with the survey and a Royal College of Psychiatrists 
bereavement support leaflet. If no response, a second pack 
was sent 1 month later.
Date collection. We used a modified QUALYCARE postal 
survey,27 highly acceptable to participants in bereavement 
research.28 This examines the last 1–2 months of the dece-
dent’s life, including quality and consistency of informa-
tion and communication with clinicians.
Analysis. Analysis compared the groups, in particular ques-
tions about communication, information sharing, aware-
ness of illness and length of stay, using independent t-tests 
and χ2 tests. Statistical significance (two-sided) was set at 
p < 0.05. For the followback survey, we calculated sample 
size estimates in relation to variables that were central to 
understanding to what extent the AMBER care bundle 
achieved its goals. Therefore, we wanted to detect poten-
tial differences in the percentage of respondents unable to 
gain sufficient information regarding a patient’s condition; 
distributions from followback surveys varied between 
39% and 64%.29,30 With power set at 80% and alpha 
at 0.05, similarly 69 cases would be required from 
each group to detect this difference. In order to detect 
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differences in the percentage of patients who knew they 
were going to die, previous studies have ranged between 
51% and 69%.31,32 With power set at 80% and alpha at 
0.05, we estimated a minimum of 113 cases would be 
required from each group to detect a similar difference.
Integration of data. The interview and survey data were 
integrated at the point of analysis, in a convergent design, 
interrogating the data around common key themes and 
questions,33 as demonstrated through the integrated results 
presented below.
Results
Participants
Contemporary interviews. A total of 23 patients and informal 
carers participated in 19 interviews (Table 1) – 8 interviews 
with patients only, 3 interviews with patient and carer 
dyads (patient and partner or spouse), and 8 interviews with 
carers only (including spouse, mother, brother, son, daugh-
ter, daughter in law, and niece), one of which was with two 
carers together. 10 AMBER care bundle and 9 comparison, 
where 11 had cancer and 8 non-cancer diagnoses (brain 
tumour, spinal tumour, dementia, stroke, hip fracture, heart 
failure, liver failure and kidney failure). Mean interview 
duration was 29 min (range: 11–123 min).
Followback survey. A total of 482 surveys were sent to the 
NOK: 261 deceased patients supported by the AMBER 
care bundle and 221 who received standard care (Table 2). 
Overall response rate was 20% (n = 95). Although the 
response rate differed between the two groups (AMBER 
care bundle 23% and comparison 16%), this was not statis-
tically significant (χ2 = 3.01, df = 1, p = 0.08).
The first section of the results will present the differ-
ences between the AMBER care bundle and standard care 
experiences for patients and carers, and the second section 
will present the similarities.
1. Exploring the AMBER care bundle and compari-
son group experiences (survey and interviews) 
– differences
In both the interviews and survey, differences emerged in 
the experiences of those in the AMBER care bundle and 
comparison groups. Specifically, these were related to 
awareness of the clinical situation and discussion and real-
isation of preferences for place of care. For each of these, 
the experiences shared in the followback survey and con-
temporary interviews are described below.
Awareness of the clinical situation
Followback survey. The AMBER care bundle family meet-
ing is an opportunity to discuss prognosis, preferences, 
priorities and concerns. Significantly more of the AMBER 
care bundle group than the comparison group reported that 
the patient was aware they were going to die from their ill-
ness (72% compared to 48%, χ2 = 4.29, p = 0.04; Table 3). 
Also, significantly more of the AMBER care bundle group 
recalled a clinician discussing with the patient that they 
were likely to die from their illness (59% compared to 32%, 
χ2 = 4.09, p = 0.04; Table 3).
Contemporary interviews. Carers supported by the AMBER 
care bundle described clinicians deliberately seeking them 
out to update them and address concerns, which repre-
sented a source of enormous support:
one of the doctors actually rung me from home at nine o clock 
at night once because she realised she’d forgotten or hadn’t 
had a chance to come and see me so that was … was really 
nice and that was much appreciated. (Cheryl, daughter of a 
man with lung cancer – AMBER)
Table 1. Interview participants.
Interviews 19
Group
 AMBER care bundle 10
 Comparison 9
Interview participants
 Patient only 8
 Patient and carer 3
 Carer(s) only 8
Patient age (years)
 40–59 6
 60–79 7
 80 and over 6
 Mean 69
 Median 70
 Range 42–93
Patient gender
 Female 8
 Male 11
Patient ethnicity
 Black African 1
 Black Caribbean 2
 White Other 3
 White British 13
Disease group
 Cancer 11
 Non-cancer 8
Patient deceased?
 Yes 18
 No 1
 <1 week after interview 6
 <1 month after interview 7
 <3 months after interview 3
 3–6 months after interview 2
 Recovered 1
Interview duration (min)
 Mean 29
 Range 11–123
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Further differences were evident in the contemporary 
interviews. Although both groups reported difficulties with 
inconsistent information, for those supported by the 
AMBER care bundle, incomplete or inconsistent informa-
tion was often described in the context of rapidly changing 
clinical situations, as a cause of clinical uncertainty, as 
illustrated below (emphasis added):
As I say it’s just … not knowing exactly like, that’s the only 
thing that bothers me … they can’t predict … but I know he is 
Table 2. Followback survey participants.
Mailed out to AMBER care bundle (n = 261) Comparison (n = 221) Combined (n = 482)
Completed and returned 23% (n = 59) 16% (n = 36) 20% (n = 95)
Refused 9% (n = 24) 10% (n = 21) 9% (n = 45)
Addressee not known 13% (n = 34) 10% (n = 21) 11% (n = 55)
No response 55% (n = 144) 64% (n = 143) 60% (n = 287)
Patient characteristics AMBER care bundle (n = 59) Comparison (n = 36) Combined (n = 95)
Age (years)
 Mean (range) 73 (28–102) 83 (61–95) 77 (28–102)
Reason for admission
 Pneumonia 20% (n = 12) 11% (n = 4) 17% (n = 16)
  Respiratory disease (COPD, bronchiectasis 
and pulmonary fibrosis)
7% (n = 4) 14% (n = 5) 10% (n = 9)
 Cancer (local and metastatic) 24% (n = 14) 11% (n = 4) 19% (n = 18)
 Sepsis (other than pneumonia) 14% (n = 8) 11% (n = 4) 13% (n = 12)
 MND, MS and neurodegenerative 10% (n = 6) 0 6% (n = 6)
 Renal failure 3% (n = 2) 5% (n = 2) 4% (n = 4)
 Heart failure and acute coronary syndromes 5% (n = 3) 11% (n = 4) 7% (n = 7)
 Dementia 2% (n = 1) 3% (n = 1) 2% (n = 2)
 Stroke and subdural haemorrhage 2% (n = 1) 17% (n = 6) 7% (n = 7)
 Liver failure and GI disease 10% (n = 6) 0% 6% (n = 6)
 Other 3% (n = 2) 17% (n = 6) 9% (n = 8)
Disease group
 Cancer 34% (20) 25% (9) 31% (29)
 Non-cancer 66% (39) 75% (27) 69% (66)
Gender
 Male 46% (n = 27) 53% (n = 19) 48% (n = 46)
 Female 54% (n = 32) 47% (n = 17) 52% (n = 49)
Ethnicity
 White British/Other 85% (n = 50) 72% (n = 26) 80% (n = 76)
 Black African/Caribbean/Other 5% (n = 3) 14% (n = 5) 9% (n = 8)
 Asian 5% (n = 3) 3% (n = 1) 4% (n = 4)
 Other 2% (n = 1) 8% (n = 3) 4% (n = 4)
 Not completed 3% (n = 2) 3% (n = 1) 3% (n = 3)
Next of kin or respondent characteristics  
 Gender
  Male 24% (n = 14) 31% (n = 11) 26% (n = 25)
  Female 76% (n = 45) 67% (n = 24) 73% (n = 69)
  Not completed 2% (n = 1) 1% (n = 1)
 Age (years)
  Mean 60 (n = 58) 65 (n = 32) 62 (n = 90)
  Range 21–87 44–91 21–91
  Not completed 1 4 5
 Ethnicity
  White British/Other 89% (n = 52) 72% (26) 82% (n = 78)
  Black African/Caribbean/Other 5% (n = 3) 13% (5) 9% (n = 8)
  Asian 0% (n = 0) 3% (1) 1% (n = 1)
  Other 3% (n = 2) 6% (2) 4% (n = 4)
  Not completed 3% (n = 2) 6% (2) 4% (n = 4)
COPD: chronic obstructive pulmonary disease; MND: motor neuron disease; MS: multiple sclerosis; GI: gastrointestinal.
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Table 3. Followback survey results.
Awareness of prognosis
 AMBER care bundle (n = 53) Comparison (n = 27) p value
Was the patient aware they were going to die because of their illness?
 Yes, certainly or probably knew 38 (72%) 13 (48%) χ2 = 4.29, df = 1, p = 0.04
  No, probably or definitely did 
not know
15 (28%) 14 (52%)
 AMBER care bundle (n = 41) Comparison (n = 22) p value
Did any health professional discuss with the patient that he or she was likely to die from the illness?
 Yes 24 (59%) 7 (32%) χ2 = 4.09, df = 1, p = 0.04
 No 17 (41%) 15 (68%)
Length of hospital stay (days)
 AMBER care bundle (n = 41) Comparison (n = 19) p value
Length of hospital stay for all 
patients
Mean: 20.3 (SD: 19.2, 
median: 14, range: 1–87)
Mean: 29.3 (SD: 20.4, 
median: 21, range: 6–70)
t-test = −1.65, df = 58, p = 0.10
 AMBER care bundle (n = 20) Comparison (n = 9) p value
Length of hospital stay for all 
patients who were discharged and 
died in a place other than hospital
Mean: 17.6 (SD: 14.6, 
median: 13.5, range: 1–87)
Mean: 21.4 (SD: 15.1, 
median: 14, range: 6–70)
t-test = −0.66, df = 27, p = 0.52
Communication and information sharing
 AMBER care bundle (n = 57) Comparison (n = 35) p value
Did you receive information about his condition that was clear and easy to understand?
 Yes, most of the time 29 (51%) 24 (69%) χ2 = 6.26, df = 2, p = 0.04
 Sometimes 16 (28%) 10 (28%)
 No, not at all 12 (21%) 1 (3%)
 AMBER care bundle (n = 55) Comparison (n = 34) p value
Do you remember receiving information on a day-to-day basis that helped you understand the reason for the care he or she 
received?
 Yes, most of the time 21 (38%) 17 (50%) χ2 = 1.54, df = 2, p = 0.46
 Sometimes 19 (35%) 11 (32%)
 No, not at all 15 (27%) 6 (18%)
 AMBER care bundle (n = 55) Comparison (n = 35) p value
Did you receive consistent information about his condition?
 Yes, most of the time 25 (45%) 18 (52%) χ2 = 2.75, df = 2, p = 0.25
 Sometimes 14 (26%) 12 (34%)
 No, not at all did not know 16 (29%) 5 (14%)
Involvement of palliative care
 AMBER care bundle (n = 48) Comparison (n = 28)
Was the patients seen by 
someone from the palliative care 
team or the Macmillan nurses at 
the hospital?
29 (60%) 17 (61%)
(Continued)
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Place of death
 AMBER care bundle (n = 51) Comparison (n = 28) p value
As far as you know, where would the patient have preferred to die?
  Home or home of relative or 
close friend
45% (n = 23) 39% (n = 11) χ2 = 3.92, df = 4, p = 0.42
 Hospice 24% (n = 12) 14% (n = 4)
 Hospital 21% (n = 11) 36% (n = 10)
  Nursing or residential care 
home
6% (n = 3) 11% (n = 3)
 Elsewhere 4% (n = 2) 0% (n = 0)  
 AMBER care bundle (n = 59) Comparison (n = 35) p value
Where did the patient die?
  Home or home of relative or 
close friend
20% (n = 12) 9% (n = 3) χ2 = 5.71, df = 3, p = 0.13
 Hospice 20% (n = 12) 9% (n = 3)
 Hospital 51% (30) 68% (24)
  Nursing or residential care 
home
9% (n = 5) 14% (n = 5)
SD: standard deviation.
Table 3. (Continued)
getting weaker. (Mary, wife of man with heart failure 
– AMBER)
Contrastingly, participants in the comparison inter-
views tended to report uncertainty as a result of the clini-
cians’ ‘assumptions’, due to their inadequate or incomplete 
knowledge, suggesting that perhaps the clinical uncer-
tainty had not been fully explained (emphasis added):
They come in everyday … the only question I’ve got and they 
can’t answer is exactly how long have I got … they don’t 
know … it’s all assumption. (Martin, man with bladder cancer 
– Comparison)
These differences suggest those supported by the AMBER 
care bundle may have more of an understanding of the clini-
cal uncertainty and its resultant impact upon clinicians’ abil-
ity to provide consistent and complete information.
Discussion and realisation of preferences for 
place of care
Followback survey. Length of hospital stay was not signifi-
cantly different between the groups: AMBER care bundle 
group mean hospital stay 20.3 days (range: 1–87 days) and 
comparison group 29.3 days (range: 6–70 days; Table 3). 
Broadly, similar proportions of patients cared for on 
AMBER care bundle wards (45%, n = 23/51) and the 
comparison group (39%, n = 11/28) were known to have 
preferred a home death. However, the numbers of AMBER 
(20%, n = 12/59) and comparison group (8%, n = 3/35) 
patients who did so (or the home of a relative or friend) 
differed, although this difference was not statistically 
significant.
Contemporary interviews. Concerns of caring for a relative 
at home were more evident among those supported by the 
AMBER care bundle than the comparison group, includ-
ing feeling unprepared practically and emotionally for the 
experience, questioning whether they would cope and 
facing the physical reality of death of a relative at 
home. Although preferred place of care was elicited and 
potentially expedited, concerns regarding discharge were 
not addressed drawing into question the quality of the 
discussions:
Even now we’re still having conversations about … are you 
going to go home and … although he wants to I don’t think 
that it’s perhaps the best place and I don’t think that he really 
thinks that it’s the best place … from a practical point of view 
… so I guess maybe you know if someone had said … actually 
… have you really thought about the implications of this … 
might have been useful … um at the time when he was saying 
yes I want to go home. (Cheryl, daughter of a man with 
stomach cancer – AMBER)
These unresolved concerns were also found in the 
followback survey free-text entries (Table 4).
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Table 4. Followback survey free-text comments.
Preferred place of care
AMBER/comparison Respondent Comment
AMBER Son of woman with cancer I felt hopeless and worried at times when my mum 
complained about pain. I didn’t know how to help her, 
especially when she was in a coma and sweating a lot. At the 
time I wished she was in a hospice.
AMBER Daughter of woman with cancer My mum was sent to a rehabilitation centre because she 
couldn’t look after herself at home. She was too ill for 
rehabilitation but the hospice did not seem to be an option. 
Had I known she didn’t have long to live, I would have made 
sure she stayed at home and I would have looked after her.
Communication
AMBER or comparison Respondent Comment
AMBER Daughter of woman with cancer Doctors were pretty poor at making time to explain things. 
Poor communication between them meant hard to know 
where we stood, next steps etc.
AMBER Daughter of woman with COPD Doctors took time to speak to me and explain what was 
wrong and what they were doing to help.
AMBER Daughter of woman with cancer It was often quite difficult to get information about her 
condition and what treatment was being given. Doctors rarely 
available to talk to at the times I was able to visit, and nurses 
were not able to discuss her case.
AMBER Son of woman with sepsis We the family were treated with kindness and kept fully 
informed.
AMBER Daughter of woman with cancer I would have appreciated knowing earlier that she was coming 
to the end of her life. I think I knew but I needed to know 
on admission that she would not survive. I needed someone 
to tell me, even though the staff may have thought I knew, I 
needed confirmation to act accordingly.
Comparison Relative of woman with sepsis They explained what they thought was wrong with her to her 
family but when death was near, never told the family that she 
was close to the end of life.
Comparison Wife of man who had a stroke Quite good communication when doctors on ward, but it was 
very difficult to find out information on a day to day basis as 
family went days without seeing a doctor.
Comparison Wife of man who had a stroke I am not sure they explained adequately the situation. He 
could not speak but his brain was intact.
Comparison Husband of woman with 
subdural haemorrhage
Care was taken, but information was never explained to me.
COPD: chronic obstructive pulmonary disease.
2. Communication concerns (survey and interviews) 
– similarities
There were also some similarities to the experiences shared 
by the two groups. Both those supported by the AMBER 
care bundle and the comparison group described chal-
lenges when communicating with clinicians. Concerns 
were related to the actual information shared and the 
process of information sharing. For each of these, the 
experiences shared in the followback survey and contem-
porary interviews are described below.
Information shared
Followback survey. Respondents from the AMBER care 
bundle group were less likely than the comparison group 
to report that information was clear and easy to understand 
(69% vs 51%, χ = 6.26, p = 0.04). However, there were no 
differences in frequency or consistency of communication 
with clinicians between the groups (Table 3).
Contemporary interviews. The impact of inconsistent infor-
mation was also described by interview participants, often 
in very emotive terms:
We were told on a Sunday evening at seven … that … we 
need to make preparations to get John either to our local 
hospital … or indeed home because there’s nothing more that 
can be done for him … and then on the Monday morning to 
arrive and be told by his consultant that … John’s doing 
remarkably well … and there’s no reason that within a couple 
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of months he shouldn’t be back up and on his feet … the 
emotional trauma for you … for all of us. (Tom, brother of 
man with spinal tumour – Comparison)
Process of information sharing
Concerns were also raised, regarding the process of infor-
mation sharing with the clinicians.
Followback survey. Respondents shared positive experiences 
of communication with clinicians but also feelings of 
abandonment at evenings and weekends. Few doctors 
were present to talk to, as described in the survey free-text 
entries (Table 4).
Contemporary interviews. Participants described the need 
for a single point of contact to provide continuity and 
avoid unnecessary confusion. Participants also described 
insensitivity in the manner information was shared. Sev-
eral evidently distressing experiences were described in 
both groups:
The doctor told me we are in a situation of diminishing returns 
and ought to let nature take its course … this was so blunt … 
I couldn’t sleep for two days. (Devan, man with lung cancer 
– AMBER)
Discussion
This first comparative evaluation of the AMBER care 
bundle found that it may be associated with increased 
frequency of discussions about prognosis with patients 
and families and improved awareness of the clinical 
situation. However, there were no significant differences 
in length of hospital stay, satisfaction with communication, 
or frequency and clarity of information shared.
The AMBER care bundle appeared to enable more of an 
understanding of the reasons underlying clinical uncertainty, 
increased awareness of the clinical situation and increased 
frequency of discussions about prognosis. However, clarity 
of information sharing was worse among the AMBER care 
bundle group than the comparison group. The use of other 
approaches such as proactive elderly advance care planning 
tools on comparison wards may have affected this. It is pos-
sible that while discussions took place among the AMBER 
care bundle group, the information was not communicated 
effectively due to lack of skills in communicating the 
complexity of clinical uncertainty and prognostication or 
increased complexity of discussions among this group with 
more information being shared, resulting in possible confu-
sion. Inadequate explanation of clinical uncertainty has 
been found to negatively affect patient and carer experi-
ences,13 and poor communication can be detrimental to 
patient experiences and understanding of prognosis, results 
and treatment plans.34 The findings from this study suggest 
that without appropriate support and training, alongside the 
AMBER care bundle, communication of information may 
remain unsatisfactory.
Those supported by the AMBER care bundle also vol-
unteered more concerns about the reality of ‘going home’ 
than the comparison group. While discussions regarding 
preferred place of care had occurred, there were many 
unresolved concerns around leaving the security of the 
hospital, how they would cope at home and the support 
that would be available. One potential criticism of the 
AMBER care bundle is the lack of emphasis on exploring 
patient and family information preferences before initiat-
ing discussions. Clinicians are poor at estimating the infor-
mation and decision making preferences of patients and 
carers.35–37 Also, patient and carer preferences often differ, 
and carers are poor at predicting the information prefer-
ences of patients.38 Further communication training should 
accompany the AMBER care bundle, particularly in light 
of recent criticism of communication in the acute hospital 
setting,14,15 to ensure discussions are individually tailored 
accommodating patients’ and carers’ preferences for infor-
mation and discussions.
Strengths and limitations
This study represents the first attempt to evaluate the 
AMBER care bundle in the acute hospital setting and has 
important strengths. The integration of the qualitative and 
quantitative data enabled the researchers to ask intersect-
ing questions, facilitating a more complete exploration of 
care supported by the AMBER care bundle. Also, this 
study involved meaningful engagement with a hard-to-
reach population who were clinically unstable, deteriorat-
ing, with limited reversibility and at risk of dying in the 
next 1–2 months. Over half of the patients interviewed 
died within 1 month of participating, and many within 
days, providing invaluable insights into experiences at 
such a challenging time.
However, the study has limitations. First, the design was 
observational. Although there was a comparative element, 
the comparison and AMBER care bundle groups were 
likely to be different in ways other than the intervention. 
Second, while this study was primarily exploratory, based 
on our sample size calculations, we failed to recruit suffi-
cient numbers to detect other potential important differ-
ences – the response rate being considered as a marker of 
success. The EPR data from which we identified the 
participants for the followback survey were sometimes of 
poor quality; some addresses were redundant or the NOK 
was deceased making it impossible to identify an appropri-
ate proxy. This was a particular problem for the comparison 
group, which had a very poor response rate. This not only 
raised general concerns for hospitals about the veracity of 
their data but also reduced the potential number of respond-
ents and will also have biased the comparison group.
 at Kings College London - ISS on December 17, 2015pmj.sagepub.comDownloaded from 
806 Palliative Medicine 29(9) 
Third, the followback survey relies on ‘proxy’ experi-
ences of bereaved caregivers rather than patient-centred 
accounts. While the validity of proxy accounts has been 
questioned,39,40 this approach is often employed27,32,41 to 
overcome difficulties of obtaining views of representative 
samples of patients. Many studies relying on patients’ 
accounts prior to death are potentially biased since they 
represent only a small proportion of patients with an iden-
tifiable terminal illness, who are relatively well and there-
fore able to participate, and are willing to take part. Fourth, 
the choice and matching of comparison wards were chal-
lenging, and it was not possible to control for other inter-
ventions which may have altered care. In particular, many 
patients were supported by a palliative care team, and this 
may have influenced the care provided.
Conclusion
This study found some potential benefits to care supported 
by the AMBER care bundle, in particular in terms of levels 
of knowledge of patients and caregivers. However, it also 
identified potential downsides, specifically concerning 
information and communication including about going 
home. This highlights the importance of ensuring adequate 
training when implementing the AMBER care bundle. Our 
study was small and may have been inadequately powered 
to detect other differences. Our data point to a need for 
robust sufficiently powered comparative evaluation of the 
AMBER care bundle and other similar tools and complex 
interventions utilised towards the end of life, including of 
potential benefits and harms. The findings also suggest 
that additional communication training is vital, as both 
groups in this study reported negative experiences.
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